Citations 3
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS
Sheremata, William, Vollmer, Timothy R. , Stone, Lael A., Willmer–Hulme, A., Köller, M.
Neurology | May 13, 2012 | Volume: 52 | Issue: 5 | Pages: 1072-1072
Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure
Stone, Lael A., Frank, Joseph A., Albert, Paul S. , Bash, C., Maloni, Heidi , McFarland, Henry F. , Calabresi, Peter A.
Neurology | May 13, 2012 | Volume: 49 | Issue: 3 | Pages: 862-869
Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI
Stone, Lael A., Bash, C., Frank, Joseph A. , McFarland, Henry F. , Calabresi, Peter A.
Neurology | May 13, 2012 | Volume: 48 | Issue: 5 | Pages: 1446-1448